Manuscripts
Showing 1556 manuscripts.
T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.
Citation
W. E. Naugler, Florence H. Yong, Vincent J. Carey, Joan Dragavon, Robert W. Coombs, Lisa M. Frenkel. T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.. Journal of Infectious Diseases. 2002. 4: 448-55.Year
2002
Journal
Journal of Infectious Diseases
Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in HIV-1 infected children.
Citation
Joseph A. Church, Coleen Cunningham, Michael Hughes, Paul Palumbo, Lynne M. Mofenson, Patricia Mastrodonato DeLora, Elaine Margaret Smith, Andrew A. Wiznia, Lynette Purdue, Elizabeth Hawkins, Prakash Sista. Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in HIV-1 infected children.. Pediatric Infectious Disease Journal. 2002. 21: 653-9.Year
2002
Journal
Pediatric Infectious Disease Journal
Study
P1005
Pediatric HIV-1 infection: Advances and Remaining Challenges.
Citation
John L. Sullivan, Katherine Ruiz Luzuriaga. Pediatric HIV-1 infection: Advances and Remaining Challenges.. AIDS Clinical Review. 2002. 22-7.Year
2002
Journal
AIDS Clinical Review
Pharmacokinetic Characteristics of Ritonavir, Stavudine, Zidovudine, and Lamivudine in HIV-infected Children
Citation
Courtney V. Fletcher, Ram Yogev, Sharon Appelbaum Nachman, Andrew A. Wiznia, Stephen Ira Pelton, Kenneth McIntosh, Kenneth Stanley. Pharmacokinetic Characteristics of Ritonavir, Stavudine, Zidovudine, and Lamivudine in HIV-infected Children. Pharmacotherapy. 2002. 24: 453-9.Year
2002
Journal
Pharmacotherapy
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir in pretreated children infected with human immunodeficiency virus type 1.
Citation
Paul Krogstad, Sophia S. Lee, George M. Johnson, Kenneth Stanley, James McNamara, John ( Jack ) Moye, Brooks Jackson, Rosaura M. Aguayo, Arry Dieudonne, Margaret Khoury, Hermann A. Mendez, Sharon Appelbaum Nachman, Andrew A. Wiznia. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir in pretreated children infected with human immunodeficiency virus type 1.. Clinical Infectious Diseases. 2002. 34: 991-1001.Year
2002
Journal
Clinical Infectious Diseases
Infrequent detection of HIV-1 specifiec, but not CMV specific, CD8+ T cell responses in young HIV-1 infected infants.
Citation
Z. A. Scott, Ellen Gould Chadwick, Lynn Gibson, Margaret McManus, Ram Yogev, Paul Palumbo, John L. Sullivan, Paula Britto, Hannah Gay, Katherine Luzuriaga. Infrequent detection of HIV-1 specifiec, but not CMV specific, CD8+ T cell responses in young HIV-1 infected infants.. Journal of Immunology. 2002. 167: 7134-40.Year
2002
Journal
Journal of Immunology
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche
Citation
Keith D. Chirgwin, Richard Hafner, Catherine Leport, Jack S. Remington, Janet Andersen, Elizabeth M. Bosler, Clemente Roque, Natasa Rajicic, Vincent J. McAuliffe, Philippe Morlat, Dushyantha T. Jayaweera, Jean-Louis Vilde, Benjamin J. Luft. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche. Clinical Infectious Diseases. 2002. 34: 1243-50. PMID: 11941551Year
2002
Journal
Clinical Infectious Diseases
Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir and saquinavir after simultaneous and staggered oral administration
Citation
Jian-Feng Lu, Terrence F. Blaschke, Charles Flexner, Susan L Rosenkranz, Lewis Sheiner. Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir and saquinavir after simultaneous and staggered oral administration. Drug Metabolism and Disposition. 2002. 30: 1455-61.Year
2002
Journal
Drug Metabolism and Disposition
A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy
Citation
Judith A. Aberg, Richard W. Price, Dorie M. Heeren, Barry Bredt. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. Journal of Infectious Diseases. 2002. 185: 1179-82.Year
2002
Journal
Journal of Infectious Diseases
Safety of Two Recombinant HIV-1 Envelope Vaccines in Neonates Born to HIV-1 Infected Women
Citation
Coleen K. Cunningham, Diane W. Wara, Minhee Kang, Terence Fenton, Elizabeth Hawkins, James McNamara, Lynne M. Mofenson, Anne-Marie Duliege, Donald P. Francis, Donald P. Francis, Elizabeth (Betsy) J. McFarland, William Borkowsky. Safety of Two Recombinant HIV-1 Envelope Vaccines in Neonates Born to HIV-1 Infected Women. Clinical Infectious Diseases. 2002. 32: 801-807.Year
2002
Journal
Clinical Infectious Diseases